• Explore /
  • Poster
  • / Angiogenesis polymorphisms profile in the prediction of clinical outcome of advanced HCC patients receiving sorafenib: Combined analysis of VEGF and HIF-1α—Final results of the ALICE-2 study.

Angiogenesis polymorphisms profile in the prediction of clinical outcome of advanced HCC patients receiving sorafenib: Combined analysis of VEGF and HIF-1α—Final results of the ALICE-2 study.

Abstract Poster

Authors

null

Luca Faloppi

Department of Medical Oncology, A.O.U. United Hospital, Polytechnic University of the Marche Region, Ancona, Italy

Luca Faloppi , Andrea Casadei Gardini , Gianluca Masi , Nicola Silvestris , Cristian Loretelli , Paola Ulivi , Caterina Vivaldi , Maristella Bianconi , Riccardo Giampieri , Alessandro Bittoni , Kalliopi Andrikou , Michela Del Prete , Stefano Cascinu , Mario Scartozzi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Translational Research

Citation

J Clin Oncol 34, 2016 (suppl 4S; abstr 280)

DOI

10.1200/jco.2016.34.4_suppl.280

Abstract #

280

Poster Bd #

E4

Abstract Disclosures

Similar Posters

First Author: Luca Faloppi

First Author: Luca Faloppi

Poster

2020 Gastrointestinal Cancers Symposium

Gene polymorphisms of CCL3, CCL4, CCL5, and CCR5 network in metastatic colorectal cancer patients treated with regorafenib.

Gene polymorphisms of CCL3, CCL4, CCL5, and CCR5 network in metastatic colorectal cancer patients treated with regorafenib.

First Author: Mitsukuni Suenaga

First Author: Madiha Naseem